Skip to main content
. 2004 Nov;6(6):813–820. doi: 10.1593/neo.04307

Figure 1.

Figure 1

Prognostic effect of STRAP amplification on DFS and OS in the untreated patient group. (A) Kaplan-Meier curves for DFS and OS of patients without adjuvant chemotherapy who are harboring tumors with STRAP amplification versus tumors with normal diploidy of STRAP. In the absence of adjuvant chemotherapy, the patients with tumors displaying STRAP amplification had a significantly longer DFS and higher OS [relative risk of recurrence: 0.27 (95% confidence interval: 0.11–0.68, P = .005) and relative risk of death: 0.26 (95% confidence interval: 0.10–0.70, P = .004)]. (B) Kaplan-Meier curves for DFS and OS of all patients without adjuvant chemotherapy. Patients harboring tumors with STRAP amplification versus pooled patients with tumors containing diploidy or deletion of STRAP (“;no amplification”).